Funding for U.S. biomedical research: the case for the scientist-advocate.
The U.S. biomedical research community finds itself at a particularly consequential moment. Since the end of the Fiscal Year (FY) 1998-2003 NIH budget doubling period, brought to fruition with bipartisan leadership, the Federal investment in biomedical research has been declining. The NIH budget has actually decreased in constant dollars since FY 2004. Across-the-board cuts included in the Budget Control Act of 2011 would result in a loss of $2.4 billion and roughly 2,300 research project grants in FY 2013 alone, unless Congress acts to intervene before January 2013. Many of the beneficiaries of NIH support view advocacy for research funding as "someone else's job". The case to reverse this mindset must be made. Members of Congress and their staffers are open to consideration of the case for sustaining Federal investments in science, even during these difficult budget times. However, the advocacy effort must be broad-based and repeatedly presented to effect change. The figures on economic return from spending on biomedical research are compelling, but they do not tell the entire story. The results of biomedical research improve and save lives every single day, a fact that should not be lost on our elected leaders.
AADR, 1619 Duke St., Alexandria, VA 22314, USA.
J T D
JT
Nurse
C H
CH
Fox
D035843:Biomedical Research / Q000191:economics*; D002017:Budgets / Q000331:legislation & jurisprudence; D035082:Federal Government; D005380:Financing, Government / Q000191:economics* / Q000331:legislation & jurisprudence; D006801:Humans; D009316:National Institutes of Health (U.S.) / Q000191:economics; D010344:Patient Advocacy; D012109:Research Support as Topic; D014481:United States